Medium materiality6/10
Bristol Myers upgraded to Buy from Hold at Argus
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Argus upgrades BMY to Buy with a $75 target; current price $65.89. Upgrade supports a bullish view.
- Target: $75
- Current price: $65.89
- Firm: Argus
- Analyst: Jasper Hellweg
Key facts
- 01
Target: $75
- 02
Posted price: $65.89
- 03
Analyst firm: Argus Research
- 04
Analyst: Jasper Hellweg
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.